Alterations in Central Neuropeptide Expression, Release, and Receptor Binding in Rats Bred for High Anxiety: Critical Role of Vasopressin

Neuropsychopharmacology

Volumn 29, Issue 1, 2004, Pages 1-14

  Wigger, Alexandra ^a   Sánchez, Mar M ^b   Mathys, Kenneth C ^b   Ebner, Karl ^c   Frank, Elisabeth ^a   Liu, Dong ^a   Kresse, Adelheid ^d   Neumann, Inga D ^e   Holsboer, Florian ^a   Plotsky, Paul M ^b   Landgraf, Rainer ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF INNSBRUCK   (Austria)

^d UNIVERSITY OF GRAZ   (Austria)

^e UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

AVP; CRH; Emotionality; HAB; Microdialysis; Oxytocin

Indexed keywords

ARGIPRESSIN; ARGIPRESSIN RECEPTOR; CORTICOTROPIN RELEASING FACTOR; DEXAMETHASONE; MESSENGER RNA; NEUROPEPTIDE; OXYTOCIN; RECEPTOR BLOCKING AGENT;

AMYGDALOID NUCLEUS; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY DISORDER; ARTICLE; BRAIN REGION; BREEDING; CONTROLLED STUDY; COPING BEHAVIOR; DEPRESSION; EMOTIONAL STRESS; HYPOTHALAMUS HYPOPHYSIS SYSTEM; HYPOTHALAMUS PERIVENTRICULAR NUCLEUS; MALE; MAZE TEST; MENTAL PATIENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN SECRETION; PROVOCATION TEST; RAT; RECEPTOR BINDING; REGULATORY MECHANISM; STRESS; STRIA TERMINALIS; THALAMUS MIDLINE NUCLEUS; ZONA INCERTA;

ANALYSIS OF VARIANCE; ANIMALS; ANXIETY; AUTORADIOGRAPHY; BEHAVIOR, ANIMAL; BINDING SITES; BREEDING; CENTRAL NERVOUS SYSTEM; CORTICOTROPIN-RELEASING HORMONE; DISEASE MODELS, ANIMAL; EXPLORATORY BEHAVIOR; GENE EXPRESSION; GENETICS, BEHAVIORAL; IN SITU HYBRIDIZATION; MALE; MAZE LEARNING; MICRODIALYSIS; NEUROPEPTIDES; OXYTOCIN; PROTEIN BINDING; RATS; RATS, INBRED STRAINS; RATS, WISTAR; REACTION TIME; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; RECEPTORS, NEUROPEPTIDE; RECEPTORS, VASOPRESSIN; RNA, MESSENGER; STRESS; SWIMMING; TIME FACTORS; VASOPRESSINS;

EID: 9144223849     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1300290     Document Type: Article

References (83)

1. Aguilera G (1994). Regulation of pituitary ACTH secretion during chronic stress. Front Neuroendocrinol 15: 321-350.
2. Bale TL, Contarino A, Smith GW, Chan R, Gold LH, Sawchenko PE et al (2000). Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress. Nat Genet 24: 410-414.
3. Bale TL, Davis AM, Auger AP, Dorsa DM, McCarthy MM (2001). CNS region-specific oxytocin receptor expression: importance in regulation of anxiety and sex behavior. J Neurosci 21: 2546-2552.
4. Champagne D, Beaulieu J, Drolet G (1998). CRFergic innervation of the paraventricular nucleus of the rat hypothalamus: a tract-tracing study. J Neuroendocrinol 10: 19-131.
5. De Kloet ER, Joels M, Oitzl M, Sutanto W (1991). Implication of brain corticosteroid receptor diversity for the adaptation syndrome concept. Meth Arch Exp Pathol 14: 104-132.
6. De Kloet ER, Oitzl MS, Joels M (1999). Stress and cognition: are corticosteroids good or bad guys? TINS 22: 422-426.
7. De Wied D, Joels M, Burbach JPH, de Jong W, de Kloet ER, Gaffori OWJ et al (1988). Vasopressin effects on the central nervous system. In: Negro-Villar A, Conn PM (eds). Peptide Hormones: Effects and Mechanisms of Action Vol. 1 CRC Press: Boca Raton, FL. pp 97-140.
8. Driscoll P, Escorihuela RM, Fernandez-Teruel A, Giorgi O, Schwegler H, Steimer T et al (1998). Genetic selection and differential stress responses. The Roman lines/strains of rats. Ann NY Acad Sci 851: 501-510.
9. Ebner K, Wotjak CT, Holsboer F, Landgraf R, Engelmann M (1999). Vasopressin released within the septal brain area during swim stress modulates the behavioral stress response in rats. Eur J Neurosci 11: 997-1002.
10. Engelmann M, Ebner K, Landgraf R, Holsboer F, Wotjak C (1999). Emotional stress triggers intrahypothalamic but not peripheral release of oxytocin in male rats. J Neuroendocrinol 11: 867-872.
11. Engelmann M, Ludwig M, Landgraf R (1992). Microdialysis administration of vasopressin and vasopressin antagonists into the septum during pole-jumping behavior in rats. Behav Neural Biol 58: 51-57.
12. Engelmann M, Ludwig M, Landgraf R (1994). Simultaneous monitoring of intracerebral release and behavior: vasopressin improves social recognition. J Neuroendocrinol 6: 391-395.
13. Engelmann M, Wotjak CT, Ludwig M, Neumann ID, Landgraf R (1996). Behavioral consequences of intracerebral vasopressin and oxytocin: focus on learning and memory. Neurosci Biobehav Rev 20: 341-358.
14. Escorihuela RM, Fernandez-Teruel A, Gil L, Aguilar R, Tobena A, Driscoll P (1999). Inbred Roman high-and low-avoidance rats: differences in anxiety, novelty-seeking, and shuttlebox behaviors. Physiol Behav 67: 19-26.
15. Gibbs DM (1986). Vasopressin and oxytocin: hypothalamic modulators of the stress response: a review. Psychoneuroendocrinology 11: 131-139.
16. Griebel G, Simiand J, Gal CSL, Wagnon J, Pascal M, Scatton B et al (2002). Anxiolytic-and antidepressant-like effects of the non-peptide vasopressin V-1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders. Proc Natl Acad Sci USA 99: 6370-6375.
17. Grigoriadis DE, Liu XJ, Vaughn J, Palmer SF, True CD, Vale WW et al (1996). 1251-Tyro-sauvagine: a novel high affinity radioligand for the pharmacological and biochemical study of human corticotropin-releasing factor 2 alpha receptors. Mol Pharmacol 50: 679-686.
18. Heinrichs SC, Lapsansky J, Lovenberg TW, De Souza EB, Chalmers DT (1997). Corticotropin-releasing factor CRF1, but not CRF2, receptors mediate anxiogenic-like behavior. Regul Peptides 71: 15-21.
19. Heinrichs SC, De Souza EB, Schultheis G, Lapsansky J, Grigoriadis DE (2002). Brain penetrance, receptor occupancy and antistress in vivo efficacy of a small molecule corticotropin-releasing factor type 1 receptor selective antagonist. Neuropsychopharmacology 27: 194-202.
20. Henniger MSH, Ohl F, Hölter SM, Weißenbacher P, Toschi N, Lörscher P et al (2000). Unconditioned anxiety and social behaviour in two rat lines selectively bred for high and low anxiety-related behaviour. Behav Brain Res 111: 153-163.
21. Herman JP, Adams D, Prewitt C (1995). Regulatory changes in neuroendocrine stress-integrative circuitry produced by a variable stress paradigm. Neuroendocrinology 61: 180-190.
22. Holsboer F (1989). Psychiatric implications of altered limbic-hypothalamic-pituitary-adrenocortical activity. Eur Arch Psychiatr Neurol Sci 238: 302-322.
23. Ivell R, Richter D (1984). Structure and comparison of the oxytocin and vasopressin genes from rat. Proc Natl Acad Sci USA 81: 2006-2010.
24. Jezova D, Ochedalski T, Glickman M, Kiss A, Aguilera G (1999). Central corticotropin-releasing hormone receptors modulate hypothalamic-pituitary- adrenocortical and sympathoadrenal activity during stress. Neuroscience 94: 797-802.
25. Keck ME, Welt T, Mueller MB, Uhr M, Ohl F, Wigger A et al (2003). Downregulation of hypothalamic vasopressinergic hyperdrive is involved in clinically relevant behavioural and neuroendocrine antidepressant drug effects. Neuropsychopharmacology 28: 235-243.
26. Keck ME, Welt T, Wigger A, Renner U, Engelmann M, Holsboer F et al (2001). The anxiolytic effect of the CRH(1) receptor antagonist R121919 depends on innate emotionality in rats. Eur J Neurosci 13: 373-380.
27. Keck ME, Wigger A, Welt T, Müller MB, Gesing A, Reul JMHM et al (2002). Vasopressin mediates the response of the combined dexamethasone/CRH test in hyper-anxious rats: implications for pathogenesis of affective disorders. Neuropsychopharmacology 26: 94-105.
28. Kehne JH, Coverdale S, McCloskey TC, Hoffman DC, Cassella JV (2000). Effects of the CRF(1) receptor antagonist, CP 154,526, in the separation-induced vocalization anxiolytic test in rat pups. Neuropharmacology 39: 1357-1367.
29. Kishimoto T, Radulovic J, Radulovic M, Lin CR, Schrick C, Hooshmand F et al (2000). Deletion of CRH R2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2. Nat Genet 24: 415-419.
30. Landgraf R (1995). Intracerebrally released vasopressin and oxytocin: measurement, mechanisms and behavioural consequences. J Neuroendocrinol 7: 243-253.
31. Landgraf R, Frank E, Aldag JM, Neumann ID, Ren X, Terwilliger EF et al (2003). Viral vector-mediated gene transfer of the vole V1a vasopressin receptor in the rat septum: improved social discrimination and active social behavior. J Neuroendocrinol 18: 403-411.
32. Landgraf R, Gerstberger R, Montkowski A, Probst JC, Wotjak CT, Holsboer F et al (1995a). snldsn;lsV1 vasopressin receptor antisense oligodeoxynucleotide into septum reduces vasopressin binding, social discrimination abilities, and anxiety-related behavior in rats. J Neurosci 15: 4250-4258.
33. Landgraf R, Kubota M, Holsboer F, Wotjak CT (1995b). Release of vasopressin and oxytocin within the brain and into blood: microdialysis and antisense targeting. In: Saito T, Kurokawa K, Yoshida S (eds). Neurohypophysis: Recent Progress of Vasopressin and Oxytocin Research. Amsterdam: Elsevier. pp 243-256.
34. Landgraf R, Wigger A (2002). High vs low anxiety-related behavior rats: an animal model of extremes in trait anxiety. Behav Genet 32: 301-314.
35. Landgraf R, Wigger A (2003). Born to be anxious: neuro-endocrine and genetic correlates of trait anxiety in HAB rats. Stress.
36. Landgraf R, Wigger A, Holsboer F, Neumann ID (1999). hyperreactive hypothalamo-pituitary-adrenocortical axis in rats bred for high anxiety-related behaviour. J Neuroendocrinol 11: 405-407.
37. Liebsch G, Landgraf R, Gerstberger R, Probst JC, Wotjak CT, Engelmann M et al (1995). Chronic infusion of a CRH1 receptor antisense oligodeoxynucleotide into the central nucleus of the amygdala reduced anxiety-related behavior in socially defeated rats. Regul Pept 59: 229-239.
38. Liebsch G, Montkowski A, Holsboer F, Landgraf R (1998a). Behavioural profiles of two Wistar rat lines selectively bred for high or low anxiety-related behaviour. Behav Brain Res 94: 301-310.
39. Liebsch G, Landgraf R, Engelmann M, Lörscher P, Holsboer F (1999). Differential behavioural effects of chronic infusion of CRH 1 and CRH 2 receptor antisense oligonucleotides into the rat brain. J Psychiatr Res 33: 153-163.
40. Liebsch G, Linthorst ACE, Neumann ID, Reul JMHM, Holsboer F, Landgraf R (1998b). Behavioral, physiological, and neuroendocrine stress responses and differential sensitivity to diazepam in two Wistar rat lines selectively bred for high-and low-anxiety-related behaviour. Neuropsychopharmacology 19: 381-396.
41. Liebsch G, Wotjak CT, Landgraf R, Engelmann M (1996). Septal vasopressin modulates anxiety-related behaviour in rats. Neurosci Lett 217: 101-104.
42. Ma XM, Lightman SL, Aguilera G (1999). Vasopressin and corticotropin-releasing hormone gene responses to novel stress in rats adapted to repeated restraint. Endocrinology 140: 3623-3632.
43. Makara GB, Kiss A, Lolait SJ, Aguilera G (1996). Hypothalamic-pituitary corticotroph function after shunting of magnocellular vasopressin and oxytocin to the hypophyseal portal circulation. Endocrinology 137: 580-586.
44. Merlo Pich E, Heinrichs SC, Rivier C, Miczek KA, Fisher DA, Koob GF (1993). Blockade of pituitary adrenal axis activation induced by peripheral immunoneutralization of corticotropin-releasing factor does not affect the behavioral response to social defeat stress in rats. Psychoneuroendocrinology 18: 495-507.
45. Neumann I, Ludwig M, Engelmann M, Pittman QJ, Landgraf R (1993). Simultaneous microdialysis in blood and brain: oxytocin and vasopressin release in response to central and peripheral osmotic stimulation and suckling in the rat. Neuroendocrinology 58: 637-645.
46. Neumann ID, Wigger A, Liebsch G, Holsboer F, Landgraf R (1998). Increased basal activity of the hypothalamo-pituitary-adrenal axis during pregnancy in rats bred for high anxiety-related behaviour. Psychoneuroendocrinology 23: 449-463.
47. Neumann ID, Wigger A, Torner L, Holsboer F, Landgraf R (2000a). Brain oxytocin inhibits basal and stress-induced activity of the hypothalamo- pituitary-adrenal axis in male and female rats: partial action within the paraventricular nucleus. J Neuroendocrinol 12: 235-243.
48. Neumann ID, Torner L, Wigger A (2000b). Brain oxytocin: differential inhibition of neuroendocrine stress responses and anxiety-related behaviour in virgin, pregnant and lactating rats. Neuroscience 95: 567-575.
49. Nijsen MJMA, Croiset G, Diamant M, De Wied D, Wiegant VM (2001). CRH signalling in the bed nucleus of the stria terminalis is involved in stress-induced cardiac vagal activation in conscious rats. Neuropsychopharmacology 24: 1-10.
50. Ohl F, Toschi N, Wigger A, Henniger MSH, Landgraf R (2001). Dimensions of emotionality in a rat model of innate anxiety. Behav Neurosci 115: 429-436.
51. Overstreet DH, Rezvani AH, Janowski DS (1992). Maudsley reactive and nonreactive rats differ only in some tasks reflecting emotionality. Physiol Behav 52: 149-152.
52. Paxinos G, Watson C (1998). The Rat Brain in Stereotaxic Coordinates. Academic Press: Sydney, Australia.
53. Pellow S, Chopin P, File SE, Briley M (1985). Validation of open: closed arms entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14: 149-167.
54. Pitkow LJ, Sharer CA, Ren X, Insel TR, Terwilliger EF, Young LJ (2001). Facilitation of affiliation and pair-bond formation by vasopressin receptor gene transfer into the ventral forebrain of a monogamous vole. J Neurosci 21: 7392-7396.
55. Plotsky P (1991). Pathways to the secretion of ACTH: a view from the portal. J Neuroendocrinol 3: 1-10.
56. Price ML, Curtis AL, Kirby LG, Valentino RJ, Lucki I (1998). Effects of corticotropin-releasing factor on brain serotonergic activity. Neuropsychopharmacology 18: 492-502.
57. Primus RJ, Yevich E, Baltazar C, Gallager DW (1997). Autoradiographic localization of CRF1 and CRF2 binding sites in adult rat brain. Neuropsychopharmacology 17: 308-316.
58. Raadsheer FC, Hoogendijk WJ, Stam FC, Tilders FJ, Swaab DF (1994). Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. Neuroendocrinology 60: 436-444.
59. Radulovic J, Fischer A, Katerkamp U, Spiess J (2000). Role of regional neurotransmitter receptors in corticotropin-releasing factor (CRF)-mediated modulation of fear conditioning. Neuropharmacology 39: 707-710.
60. Radulovic J, Ruhmann A, Liepold T, Spiess J (1999). Modulation of learning and anxiety by corticotropin-releasing factor (CRF) and stress: differential roles of CRF receptors 1 and 2. J Neurosci 19: 5016-5025.
61. Raggenbass M, Alberi S, Zaninetti M, Pierson P, Dreifuss JJ (1998). Vasopressin and oxytocin action in the brain: cellular neurophysiological studies. Prog Brain Res 119: 263-273.
62. Rivier C, Vale WW (1983). Interaction of corticotropin-releasing factor and arginine vasopressin on adrenocorticotropin secretion in vivo. Endocrinology 113: 939-942.
63. Salomé N, Viltart O, Darnaudéry M, Salchner P, Singewald N, Landgraf R et al (2002). Reliability of high and low anxiety-related behavior; influence of laboratory environment and multifactorial analysis. Behav Brain Res 136: 227-237.
64. Sánchez MM, Young LJ, Plotsky PM, Insel TR (1999). Autoradiographic and in situ hybridization localization of corticotropin- releasing factor 1 and 2 receptors in non-human primate brain. J Comp Neurol 408: 365-377.
65. Sánchez MM, Young LJ, Plotsky PM, Insel TR (2000). Distribution of corticosteroid receptors in the rhesus brain: relative absence of glucocorticoid receptors in the hippocampal formation. J Neurosci 20: 4657-4668.
66. Sapolsky RM, McEwen BS (1985). Down-regulation of neural corticosterone receptors by corticosterone and dexamethasone. Brain Res 339: 161-165.
67. Skelton KH, Nemeroff CB, Knight DL, Owens MJ (2000). Chronic administration of the triazolobenzodiazepine alprazolam produces opposite effects on corticotropin-releasing factor and urocortin neuronal systems. J Neurosci 20: 1240-1248.
68. Steckler T, Holsboer F (1999). Corticotropin-releasing hormone receptor subtypes and emotion. Biol Psychiatry 46: 1480-1508.
69. Swanson LW, Sawchenko PE (1983). Hypothalamic integration: organization of the paraventricular and supraoptic nuclei. Ann Rev Neurosci 6: 269-324.
70. Takahashi LK, Ho SP, Livanov V, Graciani N, Arneric SP (2001). Antagonism of CRF(2) receptors produces anxiolytic behavior in animal models of anxiety. Brain Res 902: 135-142.
71. Tazi A, Swerdlow NR, Le Moal M, Rivier J, Vale W, Koob GF (1987). Behavioral activation of CRF: evidence for the involvement of the ventral forebrain. Life Sci 41: 41-49.
72. Umriukhin A, Wigger A, Singewald N, Landgraf R (2002). Hypothalamic and hippocampal release of serotonin in rats bred for hyper-or hypo-anxiety. Stress 5: 299-305.
73. van Gaalen MM, Stenzel Poore MP, Holsboer F, Steckler T (2002). Effects of transgenic overproduction of CRH on anxiety-like behaviour. Eur J Neurosci 15: 2007-2015.
74. Villar MJ, Meister B, Hokfelt T (1994). Reorganization of neural peptidergic systems in the median eminence after hypophysectomy. J Neurosci 14: 5996-6012.
75. Weiss F, Paulus MP, Lorang MT, Koob GF (1992). Increases in extracellular dopamine in the nucleus accumbens by cocaine are inversely related to basal levels: effects of acute and repeated administration. J Neurosci 12: 4372-4380.
76. Wigger A, Loerscher P, Weissenbacher P, Holsboer F, Landgraf R (2001). Cross-fostering and cross-breeding of HAB and LAB rats: a genetic rat model of anxiety. Behav Genet 31: 371-382.
77. Windle RJ, Shanks N, Lightman SL, Ingram CD (1997). Central oxytocin administration reduces stress-induced corticosterone release and anxiety behavior in rats. Endocrinology 138: 2829-2834.
78. Wotjak CT, Kubota M, Liebsch G, Montkowski A, Holsboer F, Neumann I et al (1996). Release of vasopressin within the rat paraventricular nucleus in response to emotional stress: a novel mechanism of regulating adrenocorticotropic hormone secretion? J Neurosci 16: 7725-7732.
79. Wotjak CT, Ludwig M, Ebner K, Russell JA, Singewald N, Landgraf R et al (2002). Vasopressin from hypothalamic magnocellular neurons has opposite actions at the adenohypophysis and in the supraoptic nucleus on ACTH secretion. Eur J Neurosci 16: 477-485.
80. Young LJ (2002). The neurobiology of social recognition, approach and avoidance. Biol Psychiatry 51: 18-26.
81. Young LJ, Toloczko D, Insel TR (1999). Localization of vasopressin (V1a) receptor binding and mRNA in the rhesus monkey brain. J Neuroendocrinol 11: 291-297.
82. Young LJ, Wang Z, Cooper TT, Albers HE (2000). Vasopressin (V1a) receptor binding, mRNA expression and transcriptional regulation by androgen in the Syrian hamster brain. J Neuroendocrinol 12: 1179-1185.
83. 1a receptor gene expression in monogamous and nonmonogamous voles: behavioral consequences. Behav Neurosci 111: 599-605.